or Try an Advanced Search...

    Technical Analysis for FTRE - Fortrea Holdings Inc.

    Grade Last Price % Change Price Change
    D 36.35 0.00% 0.00
    FTRE closed unchanged on Friday, April 26, 2024, on 48 percent of normal volume.
    Earnings due: May 9
    *** please verify all earnings dates ***
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Up Down Flat
    Historical FTRE trend table...
    Date Alert Name Type % Chg
    Outside Day Range Expansion 0.00%
    NR7 Range Contraction 0.00%
    Gapped Down Weakness 0.00%
    50 DMA Resistance Bearish -2.42%
    Spinning Top Other -2.42%
    Up 3 Days in a Row Strength -2.42%
    Oversold Stochastic Weakness -2.42%
    Stochastic Buy Signal Bullish -1.60%
    Lower Bollinger Band Walk Weakness -1.60%
    Oversold Stochastic Weakness -1.60%
    Older End-of-Day Signals for FTRE ...

       Recent Intraday Alerts

    Alert Time
    Outside Day about 14 hours ago
    Fell Below Previous Day's Low about 14 hours ago
    60 Minute Opening Range Breakdown about 14 hours ago
    10 DMA Resistance about 16 hours ago
    60 Minute Opening Range Breakout about 19 hours ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    FTRE Chart by TradingView
    Basic chart:

    Profile

    Fortrea Holdings Inc. provides clinical development and patient access solutions to the life sciences industry. It offers phase I-IV clinical trial management, clinical pharmacology, differentiated technology enabled trial solutions, and post approval services. The company serves pharmaceutical, biotechnology, and medical device organizations. Fortrea Holdings Inc. is based in Durham, North Carolina.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Clinical Research Clinical Pharmacology Contract Research Organizations Patient Access Solutions

    Is FTRE a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Apr 11 Fortrea Announces Date for First Quarter 2024 Financial Results and Conference Call
    Mar 12 Fortrea Holdings Full Year 2023 Earnings: EPS Misses Expectations
    Mar 11 Fortrea Holdings GAAP EPS of -$0.41 misses by $0.54, revenue of $775.4M misses by $3.69M
    Mar 11 Fortrea Holdings Inc. (FTRE) Q4 2023 Earnings Call Transcript
    Mar 11 Fortrea Holdings Inc. 2023 Q4 - Results - Earnings Call Presentation
    Mar 11 Fortrea Reports Fourth Quarter and Full-Year 2023 Results; Issues Full-Year 2024 Guidance
    Mar 11 Fortrea Signs Definitive Agreement to Divest Endpoint Clinical and Patient Access Businesses to Arsenal Capital Partners
    Mar 11 Earnings Scheduled For March 11, 2024
    Feb 23 With A 3.9% Return On Equity, Is Fortrea Holdings Inc. (NASDAQ:FTRE) A Quality Stock?
    Feb 20 Fortrea Increases Patient Access Capabilities and Cold Chain Expertise with FortreaRx™ Expansion
    See more FTRE news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 41.02
    52 Week Low 24.925
    Average Volume 853,439
    200-Day Moving Average 32.15
    50-Day Moving Average 37.82
    20-Day Moving Average 37.87
    10-Day Moving Average 36.53
    Average True Range 1.32
    RSI (14) 42.53
    ADX 18.71
    +DI 18.78
    -DI 21.67
    Chandelier Exit (Long, 3 ATRs) 36.66
    Chandelier Exit (Short, 3 ATRs) 39.10
    Upper Bollinger Bands 40.88
    Lower Bollinger Band 34.86
    Percent B (%b) 0.25
    BandWidth 15.89
    MACD Line -0.49
    MACD Signal Line -0.24
    MACD Histogram -0.256
    Fundamentals Value
    Market Cap 3.23 Billion
    Num Shares 88.8 Million
    EPS 0.06
    Price-to-Earnings (P/E) Ratio 605.83
    Price-to-Sales 0.00
    Price-to-Book 0.00
    Dividend 0.00
    Dividend Yield 0.00%
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 37.76
    Resistance 3 (R3) 37.84 37.46 37.53
    Resistance 2 (R2) 37.46 37.10 37.42 37.45
    Resistance 1 (R1) 36.90 36.88 37.18 36.82 37.37
    Pivot Point 36.52 36.52 36.66 36.48 36.52
    Support 1 (S1) 35.96 36.16 36.24 35.88 35.33
    Support 2 (S2) 35.58 35.94 35.54 35.25
    Support 3 (S3) 35.02 35.58 35.18
    Support 4 (S4) 34.94